Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy

Background: No biomarkers are recommended for patients undergoing radiation-based therapy (RT) for muscle-invasive bladder cancer (MIBC). Objective: We aim to evaluate the predictive role of programmed death-ligand 1 (PD-L1) expression on the oncological outcomes of patients treated with RT for MIBC...

Full description

Bibliographic Details
Main Authors: Gautier Marcq, Gertruda Evaristo, Ronald Kool, Surashri Shinde-Jadhav, Rodrigo Skowronski, José João Mansure, Luis Souhami, Fabio Cury, Fadi Brimo, Wassim Kassouf
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:European Urology Open Science
Subjects:
Bladder-sparing approach
Muscle-invasive bladder cancer
Programmed Death-Ligand 1
Radiation-based therapy
Tumor microenvironment
Online Access:http://www.sciencedirect.com/science/article/pii/S266616832200725X

Internet

http://www.sciencedirect.com/science/article/pii/S266616832200725X

Similar Items